Published in Heart Vessels on October 27, 2010
Effects of Door-to-Balloon Times on Outcomes in Taiwanese Patients Receiving Primary Percutaneous Coronary Intervention: A Report of Taiwan Acute Coronary Syndrome Full Spectrum Registry. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2015) 1.10
Impact of hypertension on short- and long-term prognoses in patients with ST elevation myocardial infarction and without previously known diabetes. Heart Vessels (2011) 0.83
Implementation of multiple strategies for improved door-to-balloon time in patients with ST-segment elevation myocardial infarction. Heart Vessels (2013) 0.80
Debriefing to improve outcomes from critical illness: a systematic review and meta-analysis. Intensive Care Med (2013) 0.78
Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med (2006) 8.18
Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J (2005) 6.86
Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol (2006) 4.11
Time to treatment in primary percutaneous coronary intervention. N Engl J Med (2007) 3.95
2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2008) 3.70
"False-positive" cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarction. JAMA (2007) 2.89
Data feedback efforts in quality improvement: lessons learned from US hospitals. Qual Saf Health Care (2004) 2.02
Hospital improvement in time to reperfusion in patients with acute myocardial infarction, 1999 to 2002. J Am Coll Cardiol (2005) 1.69
Achieving rapid reperfusion with primary percutaneous coronary intervention remains a challenge: insights from American Heart Association's Get With the Guidelines program. Am Heart J (2008) 1.27
The impact of emergency physician-initiated primary percutaneous coronary intervention on mean door-to-balloon time in patients with ST-segment-elevation myocardial infarction. Ann Emerg Med (2007) 1.19
Prognostic value of interleukin-6 during a 3-year follow-up in patients with acute ST-segment elevation myocardial infarction. Heart Vessels (2009) 0.96
Contact-to-balloon time and door-to-balloon time after initiation of a formalized data feedback in patients with acute ST-elevation myocardial infarction. Am J Cardiol (2007) 0.90
Systems-based improvement in door-to-balloon times at a large urban teaching hospital: a follow-up study from Parkland Health and Hospital System. Circ Cardiovasc Qual Outcomes (2009) 0.89
Effect of continuous quality improvement analysis on the delivery of primary percutaneous revascularization for acute myocardial infarction: a community hospital experience. Catheter Cardiovasc Interv (2005) 0.85
Effect of audit on door-to-inflation times in primary angioplasty/stenting for acute myocardial infarction. Am J Cardiol (2001) 0.84
Routine coronary angiographic follow-up and subsequent revascularization in patients with acute myocardial infarction. Heart Vessels (2008) 0.81
An emergency physician activated protocol, 'Code STEMI' reduces door-to-balloon time and length of stay of patients presenting with ST-segment elevation myocardial infarction. Int J Clin Pract (2009) 0.80
Myocardial salvage for ST-elevation myocardial infarction with terminal QRS distortion and restoration of brisk epicardial coronary flow. Heart Vessels (2009) 0.75
One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA (2007) 5.61
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA (2006) 5.00
Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation (2004) 3.02
Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J (2008) 2.09
Clinical predictors of long-term outcomes in patients with critical limb ischemia who have undergone endovascular therapy. Angiology (2013) 2.08
Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA (2010) 1.97
Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry. Eur Heart J (2009) 1.84
Association between a novel 11-base pair deletion mutation in the promoter region of the scavenger receptor class B type I gene and plasma HDL cholesterol levels in Taiwanese Chinese. Arterioscler Thromb Vasc Biol (2003) 1.84
Dynamic blood pressure changes and recovery under different work shifts in young women. Am J Hypertens (2008) 1.58
Technical and prognostic outcomes of double-balloon pericardiotomy for large malignancy-related pericardial effusions. Chest (2002) 1.56
Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and in vivo studies. J Mol Cell Cardiol (2002) 1.53
Mediation analysis reveals a sex-dependent association between ABO gene variants and TG/HDL-C ratio that is suppressed by sE-selectin level. Atherosclerosis (2013) 1.50
Coronary stent strut avulsion in aorto-ostial in-stent restenosis: potential complication after cutting balloon angioplasty. Catheter Cardiovasc Interv (2002) 1.46
The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J (2006) 1.45
Export aspiration catheter thrombosuction before actual angioplasty in primary coronary intervention for acute myocardial infarction. Catheter Cardiovasc Interv (2002) 1.44
Dual vascular access for critical limb ischemia: immediate and follow-up results. Catheter Cardiovasc Interv (2011) 1.39
Highly increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty: implication in prevention of restenosis. Am J Kidney Dis (2004) 1.30
Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis (2008) 1.16
Myxedema associated with cardiac tamponade. Jpn Heart J (2003) 1.15
Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis (2005) 1.03
An international model to predict recurrent cardiovascular disease. Am J Med (2012) 1.02
Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry. Eur Heart J (2008) 1.02
Ethnic differences in cardiovascular risks and mortality in atherothrombotic disease: insights from the Reduction of Atherothrombosis for Continued Health (REACH) registry. Mayo Clin Proc (2011) 1.00
Severe coronary artery spasm with anaphylactoid shock caused by contrast medium--case reports. Angiology (2006) 0.99
Angiotensin II-induced apoptosis in human endothelial cells is inhibited by adiponectin through restoration of the association between endothelial nitric oxide synthase and heat shock protein 90. FEBS Lett (2004) 0.98
Denaturing high-performance liquid chromatography screening of the long QT syndrome-related cardiac sodium and potassium channel genes and identification of novel mutations and single nucleotide polymorphisms. J Hum Genet (2005) 0.97
Angiotensinogen gene haplotype and hypertension: interaction with ACE gene I allele. Hypertension (2003) 0.97
Three-dimensional reconstruction of the rabbit atrioventricular conduction axis by combining histological, desmin, and connexin mapping data. Circulation (2004) 0.94
Diagnostic detection of human lung cancer-associated antigen using a gold nanoparticle-based electrochemical immunosensor. Anal Chem (2010) 0.94
Insulin resistance is associated with C-reactive protein independent of abdominal obesity in nondiabetic Taiwanese. Metabolism (2009) 0.94
Association between C-reactive protein gene haplotypes and C-reactive protein levels in Taiwanese: interaction with obesity. Atherosclerosis (2008) 0.93
Apolipoprotein A5 gene -1131T/C polymorphism is associated with the risk of metabolic syndrome in ethnic Chinese in Taiwan. Clin Chem Lab Med (2008) 0.92
Association between functional variants of the ICAM1 and CRP genes and metabolic syndrome in Taiwanese subjects. Metabolism (2010) 0.91
The PCSK9 gene E670G polymorphism affects low-density lipoprotein cholesterol levels but is not a risk factor for coronary artery disease in ethnic Chinese in Taiwan. Clin Chem Lab Med (2009) 0.90
Xanthoma striatum palmare in a patient with primary biliary cirrhosis and hypercholesterolemia. J Gastroenterol Hepatol (2005) 0.89
The application of tissue engineering in reversing mitomycin C-induced ischemic conjunctiva. J Biomed Mater Res A (2012) 0.88
Growth-differentiation factor-15 and major cardiac events. Am J Med Sci (2014) 0.87
Congenital atresia of the left main coronary artery associated with patent ductus arteriosus and aortic regurgitation. Circ J (2008) 0.87
Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation. J Lipid Res (2004) 0.87
Genetic variations in the cholesteryl ester transfer protein gene and high density lipoprotein cholesterol levels in Taiwanese Chinese. Hum Genet (2001) 0.86
DOPA-mediated reduction allows the facile synthesis of fluorescent gold nanoclusters for use as sensing probes for ferric ions. Anal Chem (2012) 0.85
Functional polymorphisms of FGA, encoding alpha fibrinogen, are associated with susceptibility to venous thromboembolism in a Taiwanese population. Hum Genet (2005) 0.85
Regulation of macrophage immune responses by antipsychotic drugs. Immunopharmacol Immunotoxicol (2013) 0.85
Correlates of impaired global right ventricular function in patients with a reperfused acute myocardial infarction and without right ventricular infarction. J Investig Med (2013) 0.84
Homocysteine, circulating vascular cell adhesion molecule and carotid atherosclerosis in postmenopausal vegetarian women and omnivores. Atherosclerosis (2005) 0.84
Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese. Metabolism (2009) 0.84
Aortic intramural hematoma presenting as acute inferior wall MI with cardiogenic shock. Am J Emerg Med (2004) 0.84
Association of matrix metalloproteinase 9 genotypes and cardiovascular disease risk factors with serum matrix metalloproteinase 9 concentrations in Taiwanese individuals. Clin Chem Lab Med (2010) 0.84
Working the night shift causes increased vascular stress and delayed recovery in young women. Chronobiol Int (2010) 0.84
Effect of obesity on the association between common variations in the HNF1A gene region and C-reactive protein level in Taiwanese. Clin Chim Acta (2010) 0.83
Ultrasensitive electrochemical detection of biotin using electrically addressable site-oriented antibody immobilization approach via aminophenyl boronic acid. Biosens Bioelectron (2010) 0.83
Association of SELE genotypes/haplotypes with sE-selectin levels in Taiwanese individuals: interactive effect of MMP9 level. BMC Med Genet (2012) 0.83
Usefulness of paradoxical systolic blood pressure increase after exercise as a predictor of cardiovascular mortality. Am J Cardiol (2008) 0.83
Massive pulmonary embolism with anterolateral ST-segment elevation: electrocardiogram limitations and the role of echocardiogram. Am J Emerg Med (2008) 0.83
Shedding-induced gap formation contributes to gut barrier dysfunction in endotoxemia. J Trauma Acute Care Surg (2013) 0.82
Insulin resistance is the major determinant for microalbuminuria in severe hypertriglyceridemia: implication for high-risk stratification. Intern Med (2008) 0.82
The role of type III secretion system and lens material on adhesion of Pseudomonas aeruginosa to contact lenses. Invest Ophthalmol Vis Sci (2012) 0.82
The 27-bp tandem repeat polymorphism in intron 4 of the endothelial nitric oxide synthase gene is not associated with coronary artery disease in a hospital-based Taiwanese population. Cardiology (2002) 0.82
Right ventricular endocardial tumor mimicking acute massive pulmonary embolism. Am J Emerg Med (2007) 0.81
An unusual case of dual coronary artery fistulas to main pulmonary artery. Chang Gung Med J (2002) 0.81
Urban air pollution increases plasma fibrinogen and plasminogen activator inhibitor-1 levels in susceptible patients. Eur J Cardiovasc Prev Rehabil (2006) 0.81
Determinants of lower extremity amputation or revascularization procedure in patients with peripheral artery diseases: a population-based investigation. Angiology (2010) 0.80
Genetic variants associated with circulating MMP1 levels near matrix metalloproteinase genes on chromosome 11q21-22 in Taiwanese: interaction with obesity. BMC Med Genet (2013) 0.80
Cardiovascular risk profiles and outcomes of Chinese living inside and outside China. Eur J Cardiovasc Prev Rehabil (2010) 0.80
Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese. Atherosclerosis (2006) 0.80
CAG repeat polymorphism of the MEF2A gene is not associated with the risk of coronary artery disease among Taiwanese. Clin Appl Thromb Hemost (2009) 0.79
Transesophageal echocardiographic diagnosis of intracardiac entrapment of a Swan-Ganz catheter in open heart operation. J Am Soc Echocardiogr (2004) 0.79
Effect of obesity on the association between ATF3 gene haplotypes and C-reactive protein level in Taiwanese. Clin Chim Acta (2011) 0.78
Gas exchange detection of right-to-left shunt in dyspneic patients: report of three cases. Int J Cardiol (2006) 0.78
Comparison of cardiovascular co-morbidities and CPAP use in patients with positional and non-positional mild obstructive sleep apnea. BMC Pulm Med (2014) 0.78
Arterial function of carotid and brachial arteries in postmenopausal vegetarians. Vasc Health Risk Manag (2011) 0.77
Suppression of cyclic coronary flow variation and reduction of restenosis with abciximab for morphologically high-risk lesions undergoing percutaneous coronary intervention. J Cardiovasc Pharmacol (2002) 0.77
Improvement in left ventricular function following coronary stenting in patients with acute myocardial infarction: 6-month and 3-year follow-up. Int J Cardiol (2005) 0.77
Age, male gender, and atrial fibrillation predict lower extremity amputation or revascularization in patients with peripheral artery diseases: a population-based investigation. Int J Angiol (2012) 0.77
Resveratrol protects left ventricle by increasing adenylate kinase and isocitrate dehydrogenase activities in rats with myocardial infarction. Chin J Physiol (2011) 0.77
Percutaneous transvenous mitral valvulotomy normalizes elevated circulating levels of tumor necrosis factor-alpha and interleukin-6 in mitral stenosis with heart failure. Am J Cardiol (2003) 0.77
Association between an ASIC3 gene variant and insulin resistance in Taiwanese. Clin Chim Acta (2010) 0.76